BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21485707)

  • 1. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Hapka-Zmich D; Gołab M; Gwizdala M
    Acta Pol Pharm; 2011; 68(1):99-107. PubMed ID: 21485707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Wiśniewski A; Knioła D; Olejniczak M
    Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
    Kodym A; Bilski P; Domańska A; Hełminiak Ł; Jabłońska M; Jachymska A
    Acta Pol Pharm; 2012; 69(1):95-105. PubMed ID: 22574512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology of eye drops containing metronidazole.
    Kodym A; Kaczyńska-Dyba E; Kubiak B; Kukuła H
    Acta Pol Pharm; 2011; 68(1):109-14. PubMed ID: 21485708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing ceftazidime.
    Kodym A; Zawisza T; Napierała B; Kukuła H
    Acta Pol Pharm; 2006; 63(6):507-13. PubMed ID: 17438868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing cefazolin.
    Kodym A; Zawisza T; Buźka K; Kukuła H
    Acta Pol Pharm; 2006; 63(3):225-34. PubMed ID: 20085229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of cefepime in aqueous eye drops.
    Kodym A; Pawłowska M; Rumiński JK; Bartosińska A; Kieliba A
    Pharmazie; 2011 Jan; 66(1):17-23. PubMed ID: 21391430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
    Kodym A; Marcinkowski A; Kukuła H
    Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ceftazidime in a viscous eye drop formulation.
    Barnes AR; Nash S
    J Clin Pharm Ther; 1999 Aug; 24(4):299-302. PubMed ID: 10475988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
    Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V
    Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures.
    Nahata MC; Morosco RS; Fox JL
    Am J Hosp Pharm; 1992 Dec; 49(12):2954-6. PubMed ID: 1481800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical and microbiological properties of eye drops containing cefuroxime.
    Kodym A; Zawisza T; Taberska J; Kukuła H
    Acta Pol Pharm; 2006; 63(4):293-9. PubMed ID: 17203867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months.
    Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
    Cornea; 2010 Jul; 29(7):807-11. PubMed ID: 20489598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature-mediated absorption of phenylmercuric nitrate on polyethylene and polypropylene containers in chloramphenicol eye drops.
    Charoo N; Chiew M; Tay A; Lian L
    Cutan Ocul Toxicol; 2014 Sep; 33(3):242-6. PubMed ID: 24147942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.
    Stewart JT; Warren FW; Johnson SM; Fox JL; Mullaney J
    Am J Hosp Pharm; 1992 Nov; 49(11):2765-8. PubMed ID: 1471643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs.
    Stiles ML; Allen LV; Fox JL
    Am J Hosp Pharm; 1992 Nov; 49(11):2761-4. PubMed ID: 1471642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of ceftazidime and amino acids in parenteral nutrient solutions.
    Wade CS; Lampasona V; Mullins RE; Parks RB
    Am J Hosp Pharm; 1991 Jul; 48(7):1515-9. PubMed ID: 1909093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin for treatment of bacterial endophthalmitis.
    Mehta S; Armstrong BK; Kim SJ; Toma H; West JN; Yin H; Lu P; Wayman LL; Recchia FM; Sternberg P
    Retina; 2011; 31(7):1316-22. PubMed ID: 21358364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.